Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.104 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.104 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.104 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.104 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.198ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.198NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
EG.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAFORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAFNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BC.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.17.1 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.17.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.17.1 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.17.1 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.375ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.375ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.375ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.375NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
XBB.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.26.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.26.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used